Table 1 Major themes around restricted access to tumour necrosis factor inhibitors
From: Recent developments in targeting access to high cost medicines in Australia
Predetermined Interview topics |
Perceptions of PBS-restrictions on access |
Experience with application process |
Pre-PBS collaboration between the different stakeholder groups |
Post-PBS collaboration between the different stakeholder groups |
Sources of information |
Major themes emerging from data |
Access to medicines |
   Targeting access |
   Review of the PBS-restrictions |
Implications of access arrangements in practice |
   Effects on the practice of rheumatology |
   Ethical issues |
   Roles and responsibilities |
PBS Decision-making process |
   Stakeholder consultation process |
   Transparency |
Information provision |